Second COVID Pfizer/Moderna booster could be offered to Americans 50 and older - NY Times
andresr/E+ via Getty Images


Americans aged 50 and older may be given the option of receiving a second COVID-19 booster shot, The New York Times reported.
The U.S. FDA could authorize a second booster as soon as this week, the newspaper added. The CDC would then follow with their own recommendation.

The second booster would apply to the Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) vaccines.
A CDC study in February found that the efficacy of the mRNA vaccine boosters declines significantly after four months.
An FDA advisory committee meeting to discuss the use of booster shots is scheduled for April 6.
Pfizer (PFE)/BioNTech (BNTX) have asked the FDA to authorize a second booster in adults 65 and older while Moderna (MRNA) has asked the agency to approve a second booster in adults 18 and older.